Tag: letter to the editor

Letter to the Editor: Be Aware: Dupilumab Use

Letter to the Editor: Be Aware: Dupilumab Use

| March 1, 2018

by Linda S. Marcus, MD Dr. Marcus is the Director of Dermatology Valley Hospital in Ridgewood, New Jersey. Funding/financial disclosures: The author has no conflicts of interest relevant to the content of this letter. No funding was received for the preparation of this letter. Dear Editor: Dupilumab, a monoclonal antibody that attaches to the alpha subunit of […]

Continue Reading